Preferred Label : gadoteridol;
MeSH note : nonionic magnetic resonance contrast agent; structure given in first source;
CISMeF synonym : SQ 32692; altana pharma brand of gadoteridol; prohance; rovi brand of gadoteridol;
MeSH synonym : Gd-HP-DO3A; gadolinium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane; Gd-HPDO3A; Gd(DO3A); GdHPDO3A; gadolinium HP-DO3A; Gd-hydroxypropyl-D03A; gadolinium 1,4,7-tris(carboxymethyl)-10-(2'-hydroxypropyl)-1,4,7,10-tetraazacyclododecane; Gd-HP-D03A;
MeSH hyponym : SQ 32,692; SQ-32692;
MeSH Related Number : 112188-16-6 (gadoteridol);
Registry Number MeSH : 112188-16-6;
Is substance : O;
UNII : 0199MV609F;
InChIKey : DPNNNPAKRZOSMO-UHFFFAOYSA-K;
Origin ID : C062402;
UMLS CUI : C0060930;
ATC code(s)
Currated CISMeF NLP mapping
Exact mapping(s) to DCI
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3454355/fr/prohance-gadoteridol-produit-de-contraste-en-irm
2023
false
false
false
France
French
insurance, health, reimbursement
contrast media
evaluation of the transparency committee
gadoteridol
gadoteridol
magnetic resonance imaging
adult
child
spinal cord diseases
spinal diseases
whole body imaging
Magnetic resonance imaging of head and spine with contrast (procedure)
---
https://www.has-sante.fr/jcms/p_3264401/fr/prohance-gadoteridol
2021
false
false
false
France
French
evaluation of the transparency committee
gadoteridol
gadoteridol
gadolinium
heterocyclic compounds
organometallic compounds
---
https://www.has-sante.fr/portail/jcms/c_2869898/fr/prohance
https://www.has-sante.fr/portail/jcms/c_2869898/fr/prohance-gadoteridol
2018
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
gadoteridol
diagnostic uses of chemicals
injections, intravenous
angiography
magnetic resonance imaging
adult
child
gadoteridol
insurance, health, reimbursement
gadolinium
heterocyclic compounds
organometallic compounds
---
http://www.has-sante.fr/portail/jcms/c_2018882/fr/prohance
2015
false
false
false
France
French
evaluation of the transparency committee
injections, intravenous
contrast media
gadoteridol
insurance, health, reimbursement
whole body imaging
magnetic resonance imaging
brain diseases
spinal cord diseases
spinal diseases
gadoteridol
Magnetic resonance imaging of spinal cord with contrast (procedure)
Magnetic resonance imaging of brain and brain stem (procedure)
Magnetic resonance imaging of spine with contrast (procedure)
child
adult
gadolinium
heterocyclic compounds
organometallic compounds
brain diseases
spinal cord diseases
spinal diseases
---
http://www.has-sante.fr/portail/jcms/c_2049880/fr/prohance
2015
false
false
false
France
French
evaluation of the transparency committee
injections, intravenous
contrast media
gadoteridol
insurance, health, reimbursement
whole body imaging
magnetic resonance imaging
brain diseases
spinal cord diseases
spinal diseases
gadoteridol
Magnetic resonance imaging of spinal cord with contrast (procedure)
Magnetic resonance imaging of brain and brain stem (procedure)
Magnetic resonance imaging of spine with contrast (procedure)
child
adult
gadolinium
heterocyclic compounds
organometallic compounds
spinal diseases
brain diseases
spinal cord diseases
---